The role of hyperleptinaemia and low values of interleukin 10 in de novo DSA production after kidney transplantation

被引:0
|
作者
Dedinska, Ivana [1 ,2 ,3 ,5 ]
Kleinova, Patricia [1 ,2 ,3 ]
Machalekova, Katarina [4 ]
Granak, Karol [1 ,2 ,3 ]
Vnucak, Matej [1 ,2 ,3 ]
Beliancinova, Monika [1 ,2 ,3 ]
机构
[1] Univ Hosp Martin, Transplant Ctr, Martin, Slovakia
[2] Comenius Univ, Jessenius Fac Med, Bratislava, Slovakia
[3] Univ Hosp Martin, Dept Internal Dis 1, Martin, Slovakia
[4] St Elizabeth Canc Inst, Dept Pathol, Bratislava, Slovakia
[5] Univ Hosp Martin, Transplant Ctr, Kollarova 2, Martin 03601, Slovakia
关键词
Leptin; IL-10; Protocol biopsy; Kidney transplantation; LEPTIN LEVELS; BODY-FAT; POLYMORPHISMS; ADIPONECTIN; ACTIVATION; DISEASE; WEIGHT; IL-10; ALPHA; INDEX;
D O I
10.1016/j.trim.2023.101982
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: White adipose tissue secretes a number of peptide hormones. The aim of this paper was to determine the role of leptin, adiponectin and interleukin-10 and interleukin-6 on the development of graft rejection in protocol biopsy after kidney transplantation. Methods: In a prospective analysis (n = 104), we monitored the values of leptin, adiponectin, IL -6, and IL -10 prior to the transplantation and in the 3rd month after the transplantation. The protocol biopsy of the graft was performed in the 3rd month after the transplantation. The group was divided into the following according to the biopsy result: negative result, IFTA 1, borderline, and DSA positive. Results: After adjusting for the differences in the baseline recipient and donor characteristics, we identified the hyperleptinaemia baseline (HR = 2.0444, P = 0.0341) and month 3 (HR = 49.8043, P < 0.0001) as independent risk factors for borderline changes in the protocol biopsy. The hyperleptinaemia baseline (HR = 7.4979, P = 0.0071) and month 3 (HR = 9.7432, P = 0.0057) are independent risk factors for de novo DSA positivity. A low value of IL -10 month 3 is a risk factor for de novo DSA positivity (HR = 3.0746, P = 0.0388). Conclusions: Higher leptin levels and low values of IL -10 might play a role in rejection and de novo DSA production.
引用
收藏
页数:6
相关论文
共 50 条
  • [1] The Role of Hyperleptinaemia and Low Values of Interleukin 10 in De Novo Donor-Specific Antibody Production After Kidney Transplantation
    Dedinska, Ivana
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 671 - 671
  • [2] HYPERLEPTINAEMIA AND LOW VALUES OF INTERLEUKIN 10 AS RISK FACTORS FOR GRAFT REJECTION IN PROTOCOL BIOPSY AFTER KIDNEY TRANSPLANTATION
    Dedinska, Ivana
    Vnucak, Matej
    Granak, Karol
    Miklusica, Juraj
    Laca, L'udovizt
    TRANSPLANT INTERNATIONAL, 2021, 34 : 162 - 162
  • [3] Beneficial effect of ABOincompatibility on de novo DSA production after kidney transplantation
    Kobayashi, Takaaki
    Okada, Manabu
    Iwasaki, Kenta
    Horimi, Kosei
    Matsuoka, Yutaka
    Miwa, Yuko
    Uchida, Kazuharu
    Takeda, Asami
    Goto, Norihiko
    Narumi, Shunji
    Watarai, Yoshihiko
    TRANSPLANTATION, 2018, 102 : S409 - S410
  • [4] Predictive value of the evolution of De Novo DSA MFI values in kidney transplantation
    del Moral, Covadonga Lopez
    Lachmann, Nils
    Hergovits, Sabine
    Stauch, Diana
    Akifova, Aylin
    Naik, Marcel
    Osmanodja, Bilgin
    Schmidt, Danilo
    Budde, Klemens
    HLA, 2022, 99 (05) : 423 - 423
  • [5] PREDICTIVE VALUE OF THE EVOLUTION OF DE NOVO DSA MFI VALUES IN KIDNEY TRANSPLANTATION
    del Moral, Covadonga Lopez
    Lachmann, Nils
    Hergovits, Sabine
    Stauch, Diana
    Akifova, Aylin
    Naik, Marcel
    Osmanodja, Bilgin
    Schmidt, Danilo
    Budde, Klemens
    HLA, 2022, 100 : 12 - 12
  • [6] The Natural History of De Novo DSA After Kidney Transplantation.
    Lopez del Moral, C.
    Lachmann, N.
    Hergovits, S.
    Stauch, D.
    Akifova, A.
    Naik, M.
    Osmanodja, B.
    Schmidt, D.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 959 - 960
  • [7] EVEROLIMUS BASED IMMUNOSUPPRESSION POSSIBLY SUPPRESS MFI VALUES OF DE NOVO DSA AFTER PRIMARY KIDNEY TRANSPLANTATION
    Narumi, Shunji
    Watarai, Yoshihiko
    Goto, Norihiko
    Hiramitsu, Takahisa
    Tsujita, Makoto
    Okada, Manabu
    Futamura, Kenta
    Tomosugi, Toshihide
    Sakamoto, Shintarou
    Nishihira, Morikuni
    TRANSPLANT INTERNATIONAL, 2019, 32 : 60 - 60
  • [8] PROTOCOL BIOPSIES IN PATIENTS WITH SUBCLINICAL DE NOVO DSA AFTER KIDNEY TRANSPLANTATION
    Bertrand, Dominique
    Gatault, Philippe
    Jaureguy, Maite
    Garrouste, Cyril
    Bouvier, Nicolas
    Caillard, Sophie
    Lanfranco, Luca
    Galinier, Alienor
    Hau, Francoise
    Etienne, Isabelle
    Francois, Arnaud
    Guerrot, Dominique
    TRANSPLANT INTERNATIONAL, 2019, 32 : 38 - 38
  • [9] Clinical Evolution of Patients with De Novo DSA After Kidney Transplantation.
    Lopez del Moral, C.
    Lachmann, N.
    Hergovits, S.
    Stauch, D.
    Akifova, A.
    Naik, M.
    Osmanodja, B.
    Schmidt, D.
    Budde, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 384 - 384
  • [10] THE IMPACT OF CALCINEURIN INHIBITOR WITHDRAWAL ON DE NOVO DSA PRODUCTION IN LIVING DONOR KIDNEY TRANSPLANTATION
    Hiramitsu, Takahisa
    Kanda, Akiko
    Futamura, Kenta
    Tomosugi, Toshihide
    Okada, Manabu
    Norihiko, Goto
    Narumi, Shunji
    Watarai, Yoshihiko
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1952 - 1952